LIPOSIC

This brand name is authorized in Brazil, France, Hong Kong, Ireland, Netherlands, Tunisia, South Africa

Active ingredients

The drug LIPOSIC contains one active pharmaceutical ingredient (API):

1 Carbomer UNII 0A5MM307FC - CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE

Polyacrylic acid is a hydrophilic, high molecular weight polymer of carboxyvinylic acid. The gel forms a transparent lubricating and moistening film on the surface of the eye. The preparation has a pH similar to that found in the normal tear film and is slightly hypotonic with respect to tears. Polyacrylic acid relieves the symptoms of irritation linked with dry eye syndromes and protects the cornea against drying out. Read about Carbomer

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01XA20	Artificial tears and other indifferent preparations	S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals → S01XA Other ophthalmologicals
Discover more medicines within S01XA20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 503100901162419
Country: FR	Base de données publique des médicaments	Identifier(s): 67143895
Country: HK	Department of Health Drug Office	Identifier(s): 52163
Country: IE	Health Products Regulatory Authority	Identifier(s): 31219
Country: NL	Z-Index G-Standaard	Identifier(s): 15698505
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 114901
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5283171
Country: ZA	Health Products Regulatory Authority	Identifier(s): 37/15.4/0224